Receptos, Inc. (RCPT)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
231.960.00 (0.00%)
As of 3:59 PM EDT. Market open.
People also watch:
AGIORDUSESPRALDRPTCT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.00
Prev Close231.96
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52wk Range
1y Target EstN/A
Market CapN/A
P/E Ratio (ttm)N/A
BetaN/A
Volume0
Avg Vol (3m)N/A
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Zacks Small Cap Research9 months ago

    IMNP: Clinical Sites to Open for BP Trial in the U.S.…

    On November 11, 2015, Immune Pharmaceuticals, Inc. (IMNP) announced financial results for the third quarter of 2015 and provided a business update. This acceptance will enable the company to expand recruitment for the ongoing Phase 2 clinical trial to three planned clinical trial sites in the U.S., including Mount Sinai School of Medicine in New York City.

  • Motley Fool11 months ago

    2 Questions Investors Need to Ask About Biogen's Latest Deal

    The biotech giant had other options.

  • Market Realistlast year

    Opko Health Reports Weak 2Q15 Results

    Opko Health (OPK) makes up 1.25% of the SPDR S&P Biotech ETF (XBI). It is a mid-cap stock and has a market cap of ~$6 billion.